{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:41:16Z","timestamp":1790869276163,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol. Res."],"published-print":{"date-parts":[[1997]]},"DOI":"10.1007\/bf00941983","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T10:24:44Z","timestamp":1105093484000},"page":"199-206","source":"Crossref","is-referenced-by-count":84,"title":["Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate"],"prefix":"10.1007","volume":"25","author":[{"given":"M.","family":"Goepel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"R\ufffdbben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"253","volume":"45","author":"K-E Anderson","year":"1993","unstructured":"Anderson K-E (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45: 253","journal-title":"Pharmacol Rev"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0922-4106(95)90098-5","volume":"289","author":"DE Berkowitz","year":"1995","unstructured":"Berkowitz DE, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT, Schwinn DA (1995) Distribution of ?3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289: 223","journal-title":"Eur J Pharmacol"},{"key":"CR3","first-page":"121","volume":"46","author":"DB Bylund","year":"1994","unstructured":"Bylund DB, Eikenburg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RRj, Trendelenburg U (1994) IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 46: 121","journal-title":"Pharmacol Rev"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1464-410X.1989.tb05942.x","volume":"63","author":"CR Chapple","year":"1989","unstructured":"Chapple CR, Aubry ML, James S, Greengrass PM, Burnstock G, Turner-Warwick RT, Milroy EJG, Davey MJ (1989) Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation. Br J Urol 63: 487","journal-title":"Br J Urol"},{"key":"CR5","first-page":"70","volume":"44","author":"MG Eason","year":"1993","unstructured":"Eason MG, Liggett SB (1993) Human ?2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of ?2C10, ?2C4, and ?2C2 mRNA in multiple tissues. Mol Pharmacol 44: 70","journal-title":"Mol Pharmacol"},{"key":"CR6","first-page":"1287","volume":"273","author":"W Erdbr\u00fcgger","year":"1995","unstructured":"Erdbr\u00fcgger W, Raulf M, Otto T, Michel MC (1995) Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines. J Pharmacol Exp Ther 273: 1287","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-6147(96)81593-8","volume":"17","author":"D Ferguson","year":"1996","unstructured":"Ferguson D, Christopher N (1996) Urinary bladder function and drug development. Trends Pharmacol Sci 17: 161","journal-title":"Trends Pharmacol Sci"},{"key":"CR8","unstructured":"Goepel M, Erdbrugger W, Wittmann A, Michel MC (1996) Atypical affinities of ICI 118,551 at porcine ?2-adrenoceptors. Br J Pharmacol 117 (Suppl): 198P (abstract)"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(85)90048-2","volume":"107","author":"JP Hieble","year":"1985","unstructured":"Hieble JP, Caine M, Zalaznik E (1985) In vitro characterization of the ?-adrenoceptors in human prostate. Eur J Pharmacol 107: 111","journal-title":"Eur J Pharmacol"},{"key":"CR10","first-page":"267","volume":"47","author":"JP Hieble","year":"1995","unstructured":"Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RRJ (1995) International Union of Pharmacology X. Recommendation for nomenclature of ?1 arenoceptors: consensus update. Pharmacol Rev 47: 267","journal-title":"Pharmacol Rev"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-5347(17)38780-3","volume":"142","author":"S James","year":"1989","unstructured":"James S, Chapple CR, Phillips MI, Greengrass PM, Davey MJ, Turner-Warwick RT, Milroy EJG, Burnstock G (1989) Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate. J Urol 142: 438","journal-title":"J Urol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-5347(17)36170-0","volume":"149","author":"H Lepor","year":"1993","unstructured":"Lepor H, Tang R, Meretyk S, Shapiro E (1993) Alpha1 adrenoceptor subtypes in the human prostate. J Urol 149: 640","journal-title":"J Urol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-5347(17)42659-0","volume":"139","author":"RM Levin","year":"1988","unstructured":"Levin RM, Ruggieri MR, Wein AJ (1988) Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J Urol 139: 844","journal-title":"J Urol"},{"key":"CR14","first-page":"528","volume":"235","author":"CA Maggi","year":"1985","unstructured":"Maggi CA, Santicioli P, Furio M, Meli A (1985) Dual effects of clonidine on micturition reflex in urethane anesthetized rats. J Pharmacol Exp Ther 235: 528","journal-title":"J Pharmacol Exp Ther"},{"key":"CR15","first-page":"385","volume":"348","author":"MC Michel","year":"1993","unstructured":"Michel MC, B\u00fcscher R, Kerker J, Kraneis H, Erdbr\u00fcgger W, Brodde O-E (1993) ?1-Adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal ?1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 348: 385","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1474-8673.1993.tb00290.x","volume":"13","author":"MC Michel","year":"1993","unstructured":"Michel MC, Feth F, Sundermann M, Rascher W, Brodde O-E (1993) ?-Adrenoceptor desensitization in SK-N-MC cells, a human cell line containing a homogeneous population of ?1-adrenoceptors. J Anton Pharmacol 13: 425","journal-title":"J Anton Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1474-8673.1996.tb00352.x","volume":"16","author":"MC Michel","year":"1996","unstructured":"Michel MC, Gr\u00fcbbel B, Taguchi K, Verf\u00fcth F, Otto T, Kr\u00f6pfl D (1996) Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned ?1-adrenoceptor subtypes and in human prostate. J Anton Pharmacol 16: 21","journal-title":"J Anton Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.RES.60.6.837","volume":"60","author":"J Nishimura","year":"1987","unstructured":"Nishimura J, Kanaide H, Nakamura M (1987) Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta. Circ Res 60: 837","journal-title":"Circ Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0169-328X(92)90193-F","volume":"16","author":"M Per\u00e4l\u00e4","year":"1992","unstructured":"Per\u00e4l\u00e4 M, Hirvonen H, Kalimo H, Ala-Uotila S, Regan JW, Akerman KEO, Scheinin M (1992) Differential expression of two ?2-adrenergic receptor subtype mRNAs in human tissues. Mol Brain Res 16: 57","journal-title":"Mol Brain Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0140-6736(95)92117-6","volume":"346","author":"NM Resnick","year":"1995","unstructured":"Resnick NM (1995) Urinary incontinence. Lancet 346: 94","journal-title":"Lancet"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1432-1033.1991.tb15824.x","volume":"196","author":"KM Tate","year":"1991","unstructured":"Tate KM, Briend-Sutren M-M, Emorine LJ, Delavier-Klutchko C, Marullo S, Strosberg AD (1991) Expression of three human ?-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem 196: 357","journal-title":"Eur J Biochem"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(93)90527-O","volume":"249","author":"R Testa","year":"1993","unstructured":"Testa R, Guarneri L, Ibba M, Strada G, Poggesi E, Taddei C, Simonazzi I, Leonardi A (1993) Characterization of ?1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur J Pharmacol 249: 307","journal-title":"Eur J Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1476-5381.1992.tb14527.x","volume":"107","author":"T Tsujii","year":"1992","unstructured":"Tsujii T, Azuma H, Yamaguchi T, Oshima H (1992) A possible role of decreased relaxation mediated by ?-adrenoceptors in bladder outlet obstruction by benign prostatic hypertrophy. Br J Pharmacol 107: 803","journal-title":"Br J Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(95)00354-N","volume":"284","author":"A Wikberg-Matsson","year":"1995","unstructured":"Wikberg-Matsson A, Wikberg JES, Uhlen S (1995) Identification of drugs subtype-selective for ?2A-, ?2B-, and ?2C-adrenoceptors in the pig cerebellum and kidney cortex. Eur J Pharmacol 284: 271","journal-title":"Eur J Pharmacol"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00941983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00941983\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00941983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T18:41:51Z","timestamp":1556563311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00941983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997]]}},"alternative-id":["BF00941983"],"URL":"https:\/\/doi.org\/10.1007\/bf00941983","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997]]}}}